Myriad Group AG announced that Olivier Bartholot will be stepping down from his role as Chief Revenue Officer, effective December 31, 2015. Bartholot joined Myriad in September 2007 and served in an executive leadership role since August 2013, where he was responsible for all sales and revenue generation across the company.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- CHF | -.--% | -27.92% | -62.93% |
04-11 | Syncona to Sell Stake in Portfolio Company to Century Therapeutics | MT |
02-20 | Syncona’s Takeover of Freeline Therapeutics Becomes Effective | MT |
1st Jan change | Capi. | |
---|---|---|
-62.93% | 0 | |
+10.66% | 3,092B | |
+9.13% | 86.07B | |
+5.43% | 78.64B | |
-15.70% | 53.11B | |
+28.71% | 49.21B | |
+31.31% | 46.21B | |
-33.61% | 41.11B | |
+73.04% | 40.25B | |
+3.06% | 28.44B |
- Stock Market
- Equities
- MYRN Stock
- News Myriad Group AG
- Myriad Group AG Announces Cessation of Olivier Bartholot as Chief Revenue Officer, Effective December 31, 2015